Patents by Inventor Peter Farina

Peter Farina has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260285882
    Abstract: The topological analysis of chiral molecular models led to the development of a general procedure for specifying chirality. The application of this procedure to organic chemical configurations, as described earlier (1956 and before), is retained in this paper, but modified and redefined with regard to certain structure types. These changes are largely based on experience gained at the Beilstein Institute and elsewhere since 1956. The procedure is now extended to allow the treatment of both organic chemical conformations and inorganic chemical configurations up to six ligand atoms. The paper discusses the issues that arise when transferring the symbols obtained from the model's chirality specification to the nomenclature, paying particular attention to the combination of chirality symbols obtained from the general procedure with those obtained from special procedures and with trivial nomenclature systems.
    Type: Application
    Filed: March 14, 2024
    Publication date: September 24, 2026
    Applicant: AN2 Therapeutics, Inc.
    Inventors: Chun Yu LIU, Jacob John PLATTNER, Dirk Andries HEERDING, Matthew Alexander PERRY, Peter FARINA, Xianfeng LI, Stephen John BAKER, Yasheen ZHOU, Craig Matthew GOODWIN, Sarah Ruth JACOBS, Marissa Caroline AUBREY, Gregory Lee WARREN, Robert GAMPE
  • Publication number: 20250375457
    Abstract: Provided herein are methods of treating a skin-related disease or disorder (such as melasma). Also provided are pharmaceutical compositions of midostaurin or a pharmaceutically acceptable salt thereof formulated for topical administration. Further described are methods for preparing such topical pharmaceutical compositions and methods of using the same for treating a subject.
    Type: Application
    Filed: June 18, 2025
    Publication date: December 11, 2025
    Inventors: Shun CHEN, Zeren WANG, Peter FARINA, Lian WANG, Xiaoyan ZHOU, Jing SHAO
  • Publication number: 20230128252
    Abstract: Provided are pharmaceutical compositions which include an active pharmaceutical ingredient having a calculated log P in octanol-water equal or greater than about 4.0, at least one solubilizer, and optionally at least one stratum corneum penetration enhancer, wherein the pharmaceutical composition can be formulated for topical administration. In some instances, the active pharmaceutical ingredient is clofazimine.
    Type: Application
    Filed: October 11, 2022
    Publication date: April 27, 2023
    Inventors: Zeren WANG, Jun XU, Peter FARINA, Shun CHEN
  • Patent number: 5552421
    Abstract: Various substituted benzoxazoles and benzothiazoles, are described and disclosed, which are potent inhibitors of leukotriene synthesis in warm-blooded animals.
    Type: Grant
    Filed: April 6, 1995
    Date of Patent: September 3, 1996
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Edward S. Lazer, Julian Adams, Clara K. Miao, Peter Farina
  • Patent number: 5296486
    Abstract: Various substituted benzoxazoles, benzothiazoles, oxazolopyridines and thiazolopyridines are described and disclosed, compounds that are potent inhibitors of leukotriene synthesis in warm-blooded animals.
    Type: Grant
    Filed: September 4, 1992
    Date of Patent: March 22, 1994
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Edward S. Lazer, Julian Adams, Clara K. Miao, Peter Farina